Ibrahim Galal1, Khaled El-Hindawy. 1. Department of Surgery, Cairo University Hospitals, Cairo, Egypt. Ibrahim.galal2008@gmail.com
Abstract
BACKGROUND: Surgical site infection is a common complication of surgery. Its morbidities range from delayed healing to systemic sepsis. It has impact on the economy and health care resources. METHODS: This study was a prospective, randomized, double-blinded, controlled multicenter study aimed to compare triclosan-coated polyglactin 910 sutures with polyglactin 910 sutures for the reduction of surgical site infections. This article details the results from the Cairo University center. A total of 450 patients who had undergone different surgical procedures were enrolled; 230 were enrolled in the study group and 220 were enrolled in the control group. RESULTS: The study group and the control group were comparable regarding risk factors for surgical site infection. Surgical site infection incidence was 7% in the study group and 15% in the control group (P = .011). The mean extended stay as a result of infection was 3.71 days, with an average cost $91 US per day. CONCLUSIONS: Use of the triclosan-coated polyglactin 910 antimicrobial suture lead to reduction of surgical site infection and has an impact on saving health care resources. The triclosan-coated polyglactin 910 antimicrobial suture could save $1,517,727 yearly in this single center.
RCT Entities:
BACKGROUND: Surgical site infection is a common complication of surgery. Its morbidities range from delayed healing to systemic sepsis. It has impact on the economy and health care resources. METHODS: This study was a prospective, randomized, double-blinded, controlled multicenter study aimed to compare triclosan-coated polyglactin 910 sutures with polyglactin 910 sutures for the reduction of surgical site infections. This article details the results from the Cairo University center. A total of 450 patients who had undergone different surgical procedures were enrolled; 230 were enrolled in the study group and 220 were enrolled in the control group. RESULTS: The study group and the control group were comparable regarding risk factors for surgical site infection. Surgical site infection incidence was 7% in the study group and 15% in the control group (P = .011). The mean extended stay as a result of infection was 3.71 days, with an average cost $91 US per day. CONCLUSIONS: Use of the triclosan-coated polyglactin 910 antimicrobial suture lead to reduction of surgical site infection and has an impact on saving health care resources. The triclosan-coated polyglactin 910 antimicrobial suture could save $1,517,727 yearly in this single center.
Authors: Johanna Turtiainen; Eija I T Saimanen; Kimmo T Mäkinen; Antti I Nykänen; Maarit A Venermo; Ilkka T Uurto; Tapio Hakala Journal: World J Surg Date: 2012-10 Impact factor: 3.352
Authors: Dustin L Williams; Julia M Lerdahl; Bryan S Haymond; Roy D Bloebaum Journal: Antimicrob Agents Chemother Date: 2014-01-06 Impact factor: 5.191
Authors: J C Lauscher; F Grittner; A Stroux; M Zimmermann; M le Claire; H J Buhr; J P Ritz Journal: Langenbecks Arch Surg Date: 2012-04-21 Impact factor: 3.445
Authors: Kuk Hyun Jung; Seung Jong Oh; Kang Kook Choi; Su Mi Kim; Min Gew Choi; Jun Ho Lee; Jae Hyung Noh; Tae Sung Sohn; Jae Moon Bae; Sung Kim Journal: Ann Surg Treat Res Date: 2014-11-28 Impact factor: 1.859
Authors: Dustin L Williams; Bryan S Haymond; James P Beck; Paul B Savage; Vinod Chaudhary; Richard T Epperson; Brooke Kawaguchi; Roy D Bloebaum Journal: Biomaterials Date: 2012-08-30 Impact factor: 12.479
Authors: X Wu; N Z Kubilay; J Ren; B Allegranzi; P Bischoff; B Zayed; D Pittet; J Li Journal: Eur J Clin Microbiol Infect Dis Date: 2016-09-02 Impact factor: 3.267